Your browser doesn't support javascript.
loading
Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.
Seibyl, John P; Kupsch, Andreas; Booij, Jan; Grosset, Donald G; Costa, Durval C; Hauser, Robert A; Darcourt, Jacques; Bajaj, Nin; Walker, Zuzana; Marek, Kenneth; McKeith, Ian; O'Brien, John T; Tatsch, Klaus; Tolosa, Eduardo; Dierckx, Rudi A; Grachev, Igor D.
Afiliación
  • Seibyl JP; Institute for Neurodegenerative Disorders, New Haven, Connecticut jseibyl@mnimaging.com.
  • Kupsch A; Department of Neurology and Stereotactic Neurosurgery, Otto-von-Guericke-University, Magdeburg, Germany.
  • Booij J; Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Grosset DG; Institute of Neurological Sciences, Southern General Hospital and University of Glasgow, Glasgow, Scotland.
  • Costa DC; Nuclear Medicine-Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Lisbon, Portugal.
  • Hauser RA; Departments of Neurology, Molecular Pharmacology and Physiology, USF Health Byrd Parkinson's Disease and Movement Disorders Center, National Parkinson Foundation Center of Excellence, Tampa, Florida.
  • Darcourt J; Department of Nuclear Medicine, Centre Antoine Lacassagne, TIRO Research Group, University of Nice Sophia-Antipolis, Nice, France.
  • Bajaj N; Department of Clinical Neurology, National Parkinson's Foundation International Centre of Excellence, Nottingham University Hospitals NHS Trust and University of Nottingham, Queen's Medical Centre Campus, Nottingham, United Kingdom.
  • Walker Z; Division of Psychiatry, University College London, London, United Kingdom North Essex Partnership University NHS Foundation Trust, Essex, United Kingdom.
  • Marek K; Institute for Neurodegenerative Disorders, New Haven, Connecticut.
  • McKeith I; Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • O'Brien JT; Department of Psychiatry, University of Cambridge School of Clinical Medicine and Cambridgeshire and Peterborough Foundation NHS Trust, Cambridge, United Kingdom.
  • Tatsch K; Department of Nuclear Medicine, Municipal Hospital Karlsruhe, Inc., Karlsruhe, Germany.
  • Tolosa E; Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Catalonia, Spain.
  • Dierckx RA; Departments of Radiology, Nuclear Medicine, and Molecular Imaging, University Medical Centre Groningen, Groningen, The Netherlands; and.
  • Grachev ID; Medical Affairs, Life Sciences, GE Healthcare, Princeton, New Jersey.
J Nucl Med ; 55(8): 1288-96, 2014 Aug.
Article en En | MEDLINE | ID: mdl-24925885
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tomografía Computarizada de Emisión de Fotón Único / Trastornos Parkinsonianos / Demencia / Nortropanos Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Nucl Med Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tomografía Computarizada de Emisión de Fotón Único / Trastornos Parkinsonianos / Demencia / Nortropanos Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Nucl Med Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos